Logo image of ALTM

ARCADIUM LITHIUM PLC (ALTM) Stock Fundamental Analysis

NYSE:ALTM - New York Stock Exchange, Inc. - JE00BM9HZ112 - Common Stock - Currency: USD

5.74  0 (0%)

After market: 5.72 -0.02 (-0.35%)

Fundamental Rating

4

ALTM gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 84 industry peers in the Chemicals industry. ALTM scores excellent on profitability, but there are concerns on its financial health. ALTM does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

7

1. Profitability

1.1 Basic Checks

In the past year ALTM was profitable.
ALTM had a negative operating cash flow in the past year.
Of the past 5 years ALTM 4 years were profitable.
Each year in the past 5 years ALTM had a positive operating cash flow.
ALTM Yearly Net Income VS EBIT VS OCF VS FCFALTM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 100M -100M 200M 300M 400M

1.2 Ratios

ALTM's Return On Assets of 1.55% is in line compared to the rest of the industry. ALTM outperforms 43.90% of its industry peers.
ALTM has a Return On Equity (2.46%) which is comparable to the rest of the industry.
The Return On Invested Capital of ALTM (2.99%) is worse than 65.85% of its industry peers.
ALTM had an Average Return On Invested Capital over the past 3 years of 8.67%. This is above the industry average of 6.57%.
The 3 year average ROIC (8.67%) for ALTM is well above the current ROIC(2.99%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 1.55%
ROE 2.46%
ROIC 2.99%
ROA(3y)7.82%
ROA(5y)5.51%
ROE(3y)12.51%
ROE(5y)8.78%
ROIC(3y)8.67%
ROIC(5y)N/A
ALTM Yearly ROA, ROE, ROICALTM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 0 5 10 15 20 25

1.3 Margins

ALTM has a better Profit Margin (17.22%) than 95.12% of its industry peers.
ALTM's Profit Margin has improved in the last couple of years.
The Operating Margin of ALTM (37.00%) is better than 100.00% of its industry peers.
In the last couple of years the Operating Margin of ALTM has grown nicely.
With an excellent Gross Margin value of 50.04%, ALTM belongs to the best of the industry, outperforming 93.90% of the companies in the same industry.
ALTM's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 37%
PM (TTM) 17.22%
GM 50.04%
OM growth 3YN/A
OM growth 5Y3.98%
PM growth 3YN/A
PM growth 5Y5.59%
GM growth 3Y56.48%
GM growth 5Y2.73%
ALTM Yearly Profit, Operating, Gross MarginsALTM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 0 10 20 30 40 50

More info and screens

3

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), ALTM is creating some value.
ALTM has about the same amout of shares outstanding than it did 1 year ago.
Compared to 5 years ago, ALTM has less shares outstanding
Compared to 1 year ago, ALTM has an improved debt to assets ratio.
ALTM Yearly Shares OutstandingALTM Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M
ALTM Yearly Total Debt VS Total AssetsALTM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 1B 2B 3B

2.2 Solvency

Based on the Altman-Z score of 1.32, we must say that ALTM is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of ALTM (1.32) is worse than 71.95% of its industry peers.
ALTM has a Debt/Equity ratio of 0.07. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of ALTM (0.07) is better than 89.02% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.07
Debt/FCF N/A
Altman-Z 1.32
ROIC/WACC0.43
WACC6.98%
ALTM Yearly LT Debt VS Equity VS FCFALTM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 500M 1B 1.5B

2.3 Liquidity

ALTM has a Current Ratio of 1.18. This is a normal value and indicates that ALTM is financially healthy and should not expect problems in meeting its short term obligations.
ALTM has a worse Current ratio (1.18) than 89.02% of its industry peers.
A Quick Ratio of 0.65 indicates that ALTM may have some problems paying its short term obligations.
With a Quick ratio value of 0.65, ALTM is not doing good in the industry: 87.80% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.18
Quick Ratio 0.65
ALTM Yearly Current Assets VS Current LiabilitesALTM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M

More info and screens

3

3. Growth

3.1 Past

ALTM shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -84.50%.
The Earnings Per Share has been growing by 12.68% on average over the past years. This is quite good.
ALTM shows a decrease in Revenue. In the last year, the revenue decreased by -2.12%.
The Revenue has been growing by 14.80% on average over the past years. This is quite good.
EPS 1Y (TTM)-84.5%
EPS 3YN/A
EPS 5Y12.68%
EPS Q2Q%-96.65%
Revenue 1Y (TTM)-2.12%
Revenue growth 3Y45.21%
Revenue growth 5Y14.8%
Sales Q2Q%-3.93%

3.2 Future

ALTM is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -9.06% yearly.
ALTM is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 1.36% yearly.
EPS Next Y-85.93%
EPS Next 2Y-63.7%
EPS Next 3Y-35.18%
EPS Next 5Y-9.06%
Revenue Next Year-47%
Revenue Next 2Y-21%
Revenue Next 3Y-10.58%
Revenue Next 5Y1.36%

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ALTM Yearly Revenue VS EstimatesALTM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 1B 2B 3B
ALTM Yearly EPS VS EstimatesALTM Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 50 100 150 200 250

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 12.48 indicates a correct valuation of ALTM.
Based on the Price/Earnings ratio, ALTM is valued cheaper than 84.15% of the companies in the same industry.
When comparing the Price/Earnings ratio of ALTM to the average of the S&P500 Index (28.46), we can say ALTM is valued rather cheaply.
The Price/Forward Earnings ratio is 39.65, which means the current valuation is very expensive for ALTM.
Compared to the rest of the industry, the Price/Forward Earnings ratio of ALTM indicates a slightly more expensive valuation: ALTM is more expensive than 73.17% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of ALTM to the average of the S&P500 Index (92.56), we can say ALTM is valued rather cheaply.
Industry RankSector Rank
PE 12.48
Fwd PE 39.65
ALTM Price Earnings VS Forward Price EarningsALTM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, ALTM is valued a bit more expensive than the industry average as 68.29% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 16.15
ALTM Per share dataALTM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4

4.3 Compensation for Growth

ALTM has a very decent profitability rating, which may justify a higher PE ratio.
ALTM's earnings are expected to decrease with -35.18% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)0.98
EPS Next 2Y-63.7%
EPS Next 3Y-35.18%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ALTM!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ARCADIUM LITHIUM PLC

NYSE:ALTM (1/31/2025, 8:10:32 PM)

After market: 5.72 -0.02 (-0.35%)

5.74

0 (0%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)11-07 2024-11-07/amc
Earnings (Next)02-20 2025-02-20/amc
Inst Owners62.9%
Inst Owner Change-0.3%
Ins Owners0.22%
Ins Owner Change-23.68%
Market Cap6.17B
Analysts70
Price Target6.03 (5.05%)
Short Float %4.2%
Short Ratio3.19
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-38.09%
Min EPS beat(2)-74.86%
Max EPS beat(2)-1.31%
EPS beat(4)2
Avg EPS beat(4)24.76%
Min EPS beat(4)-74.86%
Max EPS beat(4)140.85%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-12.76%
Min Revenue beat(2)-25.87%
Max Revenue beat(2)0.35%
Revenue beat(4)1
Avg Revenue beat(4)-20.95%
Min Revenue beat(4)-48.27%
Max Revenue beat(4)0.35%
Revenue beat(8)5
Avg Revenue beat(8)383.14%
Revenue beat(12)9
Avg Revenue beat(12)424.35%
Revenue beat(16)13
Avg Revenue beat(16)364.11%
PT rev (1m)-3.17%
PT rev (3m)3.8%
EPS NQ rev (1m)317.21%
EPS NQ rev (3m)-86.28%
EPS NY rev (1m)1.8%
EPS NY rev (3m)-21.96%
Revenue NQ rev (1m)-2.21%
Revenue NQ rev (3m)-23.45%
Revenue NY rev (1m)-0.79%
Revenue NY rev (3m)-7.52%
Valuation
Industry RankSector Rank
PE 12.48
Fwd PE 39.65
P/S 6.86
P/FCF N/A
P/OCF N/A
P/B 0.98
P/tB 1.25
EV/EBITDA 16.15
EPS(TTM)0.46
EY8.01%
EPS(NY)0.14
Fwd EY2.52%
FCF(TTM)-0.92
FCFYN/A
OCF(TTM)-0.11
OCFYN/A
SpS0.84
BVpS5.85
TBVpS4.59
PEG (NY)N/A
PEG (5Y)0.98
Profitability
Industry RankSector Rank
ROA 1.55%
ROE 2.46%
ROCE 3.59%
ROIC 2.99%
ROICexc 3.04%
ROICexgc 3.57%
OM 37%
PM (TTM) 17.22%
GM 50.04%
FCFM N/A
ROA(3y)7.82%
ROA(5y)5.51%
ROE(3y)12.51%
ROE(5y)8.78%
ROIC(3y)8.67%
ROIC(5y)N/A
ROICexc(3y)11.3%
ROICexc(5y)N/A
ROICexgc(3y)11.89%
ROICexgc(5y)N/A
ROCE(3y)10.42%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y-6.41%
ROICexc growth 3YN/A
ROICexc growth 5Y-8.15%
OM growth 3YN/A
OM growth 5Y3.98%
PM growth 3YN/A
PM growth 5Y5.59%
GM growth 3Y56.48%
GM growth 5Y2.73%
F-Score2
Asset Turnover0.09
Health
Industry RankSector Rank
Debt/Equity 0.07
Debt/FCF N/A
Debt/EBITDA 1.04
Cap/Depr 1013.33%
Cap/Sales 96.2%
Interest Coverage 13.07
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.18
Quick Ratio 0.65
Altman-Z 1.32
F-Score2
WACC6.98%
ROIC/WACC0.43
Cap/Depr(3y)948.94%
Cap/Depr(5y)844.93%
Cap/Sales(3y)36.62%
Cap/Sales(5y)40.07%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-84.5%
EPS 3YN/A
EPS 5Y12.68%
EPS Q2Q%-96.65%
EPS Next Y-85.93%
EPS Next 2Y-63.7%
EPS Next 3Y-35.18%
EPS Next 5Y-9.06%
Revenue 1Y (TTM)-2.12%
Revenue growth 3Y45.21%
Revenue growth 5Y14.8%
Sales Q2Q%-3.93%
Revenue Next Year-47%
Revenue Next 2Y-21%
Revenue Next 3Y-10.58%
Revenue Next 5Y1.36%
EBIT growth 1Y-29.67%
EBIT growth 3YN/A
EBIT growth 5Y19.38%
EBIT Next Year-66.41%
EBIT Next 3Y-14.61%
EBIT Next 5Y2.1%
FCF growth 1Y-4441.23%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-139.35%
OCF growth 3Y261.37%
OCF growth 5Y26.44%